IM CANNABIS CORP
NASDAQ: IMCC (IM Cannabis Corp.)
Last update: 4 hours ago2.20
-0.80 (-26.67%)
| Previous Close | 3.00 |
| Volume | 128,096 |
| Price / Sales | 0.020 |
| Price / Book | 0.950 |
| 52 Weeks Range |
| Profit Margin | -8.60% |
| Operating Margin (TTM) | 1.26% |
| Diluted EPS (TTM) | -1.38 |
| Quarterly Revenue Growth (YOY) | 3.60% |
| Total Debt/Equity (MRQ) | 497.26% |
| Current Ratio (MRQ) | 0.720 |
| Operating Cash Flow (TTM) | 4.01 M |
| Levered Free Cash Flow (TTM) | -6.63 M |
| Return on Assets (TTM) | -10.46% |
| Return on Equity (TTM) | -96.83% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Drug Manufacturers - Specialty & Generic (US) | Mixed | Bullish |
| Drug Manufacturers - Specialty & Generic (Global) | Mixed | Bullish | |
| Stock | IM Cannabis Corp. | Mixed | Mixed |
AIStockmoo Score
| Analyst Consensus | NA |
| Insider Activity | NA |
| Price Volatility | -4.5 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | 4.0 |
| Average | -0.86 |
|
IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority revenue is generated from Germany, and also has its presence in Israel. |
|
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Investment Style | Small Value |
| % Held by Insiders | 75.95% |
| % Held by Institutions | 3.87% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Stonex Group Inc. | 30 Jun 2026 | 774 |
| Hidden Cove Wealth Management, Llc | 30 Jun 2026 | 476 |
| Bank Of Montreal /Can/ | 30 Jun 2026 | 404 |
| Federation Des Caisses Desjardins Du Quebec | 30 Jun 2026 | 63 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |